$5.30
-0.07-1.30%
Pre-Market: 4:03 AM EDT
Comments
Loading...
Maravai LifeSciences (MRVI) Forecast
NewsEarningsMaravai LifeSciences (MRVI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestMaravai LifeSciences (NASDAQ:MRVI) Stock Quotes, Forecast and News Summary
Maravai LifeSciences Stock (NASDAQ: MRVI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Maravai LifeSciences (MRVI) stock?
You can purchase shares of Maravai LifeSciences (NASDAQ:MRVI) through any online brokerage.
Who are Maravai LifeSciences (MRVI) competitors?
Other companies in Maravai LifeSciences’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
What is the forecast, or price target, for Maravai LifeSciences (MRVI) stock?
Maravai LifeSciences has a consensus price target of $12.77.
What is the current price for Maravai LifeSciences (MRVI)?
The stock price for Maravai LifeSciences (NASDAQ: MRVI) is $5.3 last updated December 23, 2024 at 4:03 AM EST.
Does Maravai LifeSciences (MRVI) pay a dividend?
There are no upcoming dividends for Maravai LifeSciences.
When is Maravai LifeSciences (NASDAQ:MRVI) reporting earnings?
Maravai LifeSciences’s Q4 earnings are confirmed for Thursday, February 20, 2025.
Is Maravai LifeSciences (MRVI) going to split?
There is no upcoming split for Maravai LifeSciences.
What sector and industry does Maravai LifeSciences (MRVI) operate in?
Maravai LifeSciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.